AKT1 and lung carcinoma: In this study, we demonstrated that tumor-secreted CXCL5 induces phosphorylation of the PXN/AKT pathway, leading to PD-L1 upregulation in lung cancer and enabling the evasion of immune surveillance by CD8+ T cells.